Literature DB >> 28696202

Animal models for personalized treatment options.

Iduna Fichtner, Konrad Klinghammer, Diana Behrens, Susanne Flechsig, Jana Rolff, Michael Becker, Annika Wulf-Goldenberg, Maria Stecklum, Maria Rivera, Bernadette Brzezicha, Burkhard Jandrig, Jens Hoffmann.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28696202     DOI： 10.5414/CPXCES15EA09

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  3 in total

1.  A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies.

Authors:  Dennis Gürgen; Michael Becker; Mathias Dahlmann; Susanne Flechsig; Elke Schaeffeler; Florian A Büttner; Christian Schmees; Regina Bohnert; Jens Bedke; Matthias Schwab; Johann J Wendler; Martin Schostak; Burkhard Jandrig; Wolfgang Walther; Jens Hoffmann
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

2.  Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.

Authors:  Marissa Mattar; Craig R McCarthy; Amanda R Kulick; Besnik Qeriqi; Sean Guzman; Elisa de Stanchina
Journal:  Front Oncol       Date:  2018-02-19       Impact factor: 6.244

Review 3.  Drug-adapted cancer cell lines as preclinical models of acquired resistance.

Authors:  Martin Michaelis; Mark N Wass; Jindrich Cinatl
Journal:  Cancer Drug Resist       Date:  2019-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.